Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.
Henderson Heads HHS Preparedness Office; NCI Awards $22M Southern Cohort Study.
Detroit’s “Dr. Vee” Honored For 50 Years In Medicine.
In Setback For Generics, Court Overturns FDA.
Advisors Suggest Consortia For Lung Cancer Research.
Young Elected ACS President, Von eschenback Pres.-Elect.
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Tumors are able to form with no DNA mutations, fly study shows
- From clinician scientist to nonprofit CEO